Tower Research Capital LLC (Trc) Ideaya Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,390 shares of IDYA stock, worth $104,833. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,390
Previous 14,953 70.64%
Holding current value
$104,833
Previous $524,000 73.47%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$30.37 - $43.05 $320,798 - $454,737
-10,563 Reduced 70.64%
4,390 $139,000
Q2 2024

Aug 13, 2024
BUY
$34.37 - $43.46 $497,540 - $629,126
14,476 Added 3034.8%
14,953 $524,000
Q1 2024

May 15, 2024
SELL
$34.2 - $47.13 $135,432 - $186,634
-3,960 Reduced 89.25%
477 $20,000
Q4 2023

Feb 13, 2024
BUY
$24.59 - $35.83 $77,015 - $112,219
3,132 Added 240.0%
4,437 $157,000
Q3 2023

Nov 14, 2023
SELL
$21.07 - $29.77 $1,559 - $2,202
-74 Reduced 5.37%
1,305 $35,000
Q2 2023

Aug 14, 2023
SELL
$13.33 - $25.53 $92,830 - $177,790
-6,964 Reduced 83.47%
1,379 $32,000
Q1 2023

May 09, 2023
BUY
$13.49 - $18.72 $73,587 - $102,117
5,455 Added 188.89%
8,343 $115,000
Q4 2022

Feb 10, 2023
BUY
$14.47 - $18.17 $11,966 - $15,026
827 Added 40.13%
2,888 $52,000
Q3 2022

Nov 10, 2022
SELL
$9.24 - $15.79 $13,573 - $23,195
-1,469 Reduced 41.61%
2,061 $31,000
Q2 2022

Aug 15, 2022
BUY
$8.28 - $13.88 $24,897 - $41,737
3,007 Added 574.95%
3,530 $49,000
Q1 2022

May 12, 2022
SELL
$11.18 - $24.02 $158,823 - $341,228
-14,206 Reduced 96.45%
523 $6,000
Q4 2021

Feb 14, 2022
BUY
$20.95 - $26.88 $235,834 - $302,588
11,257 Added 324.22%
14,729 $348,000
Q3 2021

Nov 15, 2021
BUY
$17.26 - $27.08 $11,667 - $18,306
676 Added 24.18%
3,472 $88,000
Q2 2021

Aug 16, 2021
SELL
$17.76 - $24.83 $11,153 - $15,593
-628 Reduced 18.34%
2,796 $59,000
Q1 2021

May 17, 2021
SELL
$13.48 - $23.77 $5,486 - $9,674
-407 Reduced 10.62%
3,424 $80,000
Q4 2020

Feb 16, 2021
SELL
$12.17 - $17.52 $94,487 - $136,025
-7,764 Reduced 66.96%
3,831 $54,000
Q3 2020

Nov 16, 2020
BUY
$11.22 - $14.46 $123,352 - $158,973
10,994 Added 1829.28%
11,595 $146,000
Q2 2020

Aug 13, 2020
BUY
$3.59 - $18.57 $2,157 - $11,160
601 New
601 $9,000
Q1 2020

May 15, 2020
SELL
$3.03 - $10.58 $1,321 - $4,612
-436 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$5.34 - $9.09 $6,755 - $11,498
-1,265 Reduced 74.37%
436 $3,000
Q3 2019

Nov 05, 2019
SELL
$6.06 - $10.91 $1,727 - $3,109
-285 Reduced 14.35%
1,701 $15,000
Q2 2019

Aug 13, 2019
BUY
$9.58 - $11.95 $19,025 - $23,732
1,986 New
1,986 $20,000

Others Institutions Holding IDYA

# of Institutions
213
Shares Held
81M
Call Options Held
69K
Put Options Held
20K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.15B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email